Consulting Agreements in the Pharmaceuticals Industry

496 Contracts & Agreements

Browse by Company

4Front Ventures Corp. (2 contracts)
Acacia Diversified Holdings, Inc. (1)
ACELRX PHARMACEUTICALS INC (1)
Acer Therapeutics Inc. (3)
ACHILLION PHARMACEUTICALS INC (1)
Aclaris Therapeutics, Inc. (7)
Acreage Holdings, Inc. (1)
ADIAL PHARMACEUTICALS, INC. (6)
Aegerion Pharmaceuticals, Inc. (6)
AEOLUS PHARMACEUTICALS, INC. (2)
AERIE PHARMACEUTICALS INC (1)
Aerpio Pharmaceuticals, Inc. (2)
AGILE THERAPEUTICS INC (1)
Akers Biosciences, Inc. (3)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (4)
ALDER BIOPHARMACEUTICALS INC (4)
ALIMERA SCIENCES INC (3)
Allergan, plc (2)
ALSERES PHARMACEUTICALS INC (2)
Altus Pharmaceuticals Inc. (2)
Amag Pharmaceuticals (1)
AmeriCann, Inc. (2)
Ampio Pharmaceuticals, Inc. (1)
Anacor Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (5)
Apimeds Pharmaceuticals US, Inc. (1)
Applied BioSciences Corp. (1)
APRICUS BIOSCIENCES, INC. (1)
ARADIGM CORP (2)
Aralez Pharmaceuticals Inc. (3)
ARIAD PHARMACEUTICALS INC (1)
Artemis Therapeutics, Inc. (3)
ARVINAS, INC. (1)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (1)
Atea Pharmaceuticals, Inc. (3)
AVALON PHARMACEUTICALS INC (4)
AVENUE THERAPEUTICS, INC. (1)
AXIM BIOTECHNOLOGIES, INC. (1)
Axsome Therapeutics, Inc. (1)
Bakhu Holdings, Corp. (8)
Bespoke Extracts, Inc. (1)
Big Rock Partners Acquisition Corp. (5)
BIODELIVERY SCIENCES INTERNATIONAL INC (1)
BioPharmX Corp (2)
BODY & MIND INC. (5)
Bright Green Corp (1)
Canbiola, Inc. (9)
Cannabics Pharmaceuticals Inc. (2)
CANNAPHARMARX, INC. (2)
Cantabio Pharmaceuticals Inc. (3)
Cara Therapeutics, Inc. (1)
CASSAVA SCIENCES INC (2)
Cerecor Inc. (1)
Charlotte's Web Holdings, Inc. (1)
CHINA PEDIATRIC PHARMACEUTICALS, INC. (1)
China Pharmaceuticals Inc (1)
China QinBa Pharmaceuticals, Inc. (1)
Clearside Biomedical, Inc. (2)
Cocrystal Pharma, Inc. (1)
CoLucid Pharmaceuticals, Inc. (2)
Context Therapeutics Inc. (5)
Corcept Therapeutics Incorporated (2)
CorMedix Inc. (1)
COSMO VENTURES INC (1)
Cure Pharmaceutical Holding Corp. (1)
Dermata Therapeutics, Inc. (2)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (1)
Elanco Animal Health Inc (1)
Eleison Pharmaceuticals Inc (6)
Elixir Pharmaceuticals, Inc. (3)
Eloxx Pharmaceuticals, Inc. (1)
ENCYSIVE PHARMACEUTICALS INC (2)
EPIX Pharmaceuticals, Inc. (1)
Eton Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (2)
Exactus, Inc. (6)
EYEGATE PHARMACEUTICALS INC (1)
EYENOVIA, INC. (2)
EyePoint Pharmaceuticals, Inc. (1)
EYETECH PHARMACEUTICALS INC (3)
Fresenius Kabi Pharmaceuticals Holding, Inc. (2)
Fulcrum Therapeutics, Inc. (2)
Furiex Pharmaceuticals, Inc. (1)
Gala Pharmaceutical Inc. (1)
GB SCIENCES INC (1)
GRAYBUG VISION, INC. (2)
GREEN HYGIENICS HOLDINGS INC. (6)
GridIron BioNutrients, Inc. (1)
GUILFORD PHARMACEUTICALS INC (2)
HARROW HEALTH, INC. (15)
Horizon Pharma plc (2)
iANTHUS CAPITAL HOLDINGS, INC. (2)
Ikena Oncology, Inc. (1)
INNOVATE BIOPHARMACEUTICALS, INC. (6)
Innoviva, Inc. (1)
INSPIRE PHARMACEUTICALS INC (1)
Intra-Cellular Therapies, Inc. (1)
Item 9 Labs Corp. (1)
Iterum Therapeutics plc (5)
Jiangbo Pharmaceuticals, Inc. (1)
JUNIPER PHARMACEUTICALS INC (2)
Kaya Holdings, Inc. (1)
KEMPHARM, INC (1)
KING PHARMACEUTICALS INC (3)
KOS PHARMACEUTICALS INC (1)
Lexaria Bioscience Corp. (13)
Liquidia Technologies Inc (1)
Lumena Pharmaceuticals, Inc. (1)
MARINUS PHARMACEUTICALS INC (1)
MedMen Enterprises, Inc. (1)
MEMORY PHARMACEUTICALS CORP (2)
Menlo Therapeutics Inc. (1)
MICROCHANNEL TECHNOLOGIES CORP (2)
MiddleBrook Pharmaceuticals, Inc. (5)
Milestone Pharmaceuticals Inc. (1)
MJ Holdings, Inc. (6)
Molecular Insight Pharmaceuticals, Inc. (2)
Mylan N.V. (2)
Nabriva Therapeutics plc (7)
NEKTAR THERAPEUTICS (2)
Neuralstem, Inc. (1)
NewBridge Global Ventures, Inc. (3)
NEXIEN BIOPHARMA, INC. (1)
Notis Global, Inc. (4)
NovaBay Pharmaceuticals, Inc. (5)
Novan, Inc. (1)
NUCRYST Pharmaceuticals Corp. (1)
NURX PHARMACEUTICALS, INC. (1)
OCULAR THERAPEUTIX, INC (5)
OMEROS CORP (1)
One World Pharma, Inc. (1)
OPIANT PHARMACEUTICALS, INC. (1)
OptiNose, Inc. (3)
ORAMED PHARMACEUTICALS INC. (15)
OSI PHARMACEUTICALS INC (5)
Pacira Pharmaceuticals, Inc. (6)
Paratek Pharmaceuticals, Inc. (1)
PaxMedica, Inc. (2)
PEAK PHARMACEUTICALS, INC. (1)
PENWEST PHARMACEUTICALS CO (1)
PetLife Pharmaceuticals, Inc. (2)
Pfizer (1)
Pharmagreen Biotech Inc. (1)
PHARMOS CORP (2)
Pivot Pharmaceuticals Inc. (5)
PLx Pharma Inc. (1)
PONIARD PHARMACEUTICALS, INC. (1)
Processa Pharmaceuticals, Inc. (1)
Profile Solutions, Inc. (3)
ProPhase Labs, Inc. (1)
Pulmatrix, Inc. (3)
QUANTA INC (2)
RADIENT PHARMACEUTICALS Corp (8)
Recro Pharma, Inc. (1)
RELMADA THERAPEUTICS, INC. (6)
RespireRx Pharmaceuticals Inc. (5)
ROCK CREEK PHARMACEUTICALS, INC. (1)
SANCILIO PHARMACEUTICALS COMPANY, INC. (1)
SAVIENT PHARMACEUTICALS INC (1)
SCICLONE PHARMACEUTICALS INC (1)
SIGA TECHNOLOGIES INC (4)
Sonoma Pharmaceuticals, Inc. (5)
Strongbridge Biopharma plc (1)
SUNWIN STEVIA INTERNATIONAL, INC. (4)
Supernus Pharmaceuticals, Inc. (3)
SYNERGY PHARMACEUTICALS, INC. (4)
Targeted Medical Pharma, Inc. (3)
Tarsus Pharmaceuticals, Inc. (1)
TAURIGA SCIENCES, INC. (3)
Terra Tech Corp. (2)
TETRALOGIC PHARMACEUTICALS CORP (2)
TETRAPHASE PHARMACEUTICALS INC (1)
TFF Pharmaceuticals, Inc. (4)
The Medicines Company (6)
TherapeuticsMD, Inc. (6)
Theravance Biopharma, Inc. (2)
Theseus Pharmaceuticals, Inc. (2)
TIBET PHARMACEUTICALS, INC. (4)
Trevi Therapeutics, Inc. (2)
Tribute Pharmaceuticals Canada Inc. (2)
Upjohn Inc (1)
Urigen Pharmaceuticals, Inc. (2)
Urovant Sciences Ltd. (1)
Vallon Pharmaceuticals, Inc. (4)
Ventyx Biosciences, Inc. (3)
Verrica Pharmaceuticals Inc. (1)
VIA Pharmaceuticals, Inc. (1)
Vireo Health International, Inc. (3)
Virpax Pharmaceuticals, Inc. (5)
VIVUS INC (1)
Vyrix Pharmaceuticals, Inc. (1)
Wave Life Sciences Ltd. (1)
WEED, INC. (1)
XERIS PHARMACEUTICALS INC (1)
ZOGENIX, INC. (1)
Zomedica Pharmaceuticals Corp. (7)

Recent Contracts

First Amendment to Independent Contractor Agreement with Chaudhry U Consulting Inc (Virpax Pharmaceuticals, Inc., Filed With SEC on December 30, 2024)
First Amendment to Independent Contractor Agreement with Jat Consulting Corp (Virpax Pharmaceuticals, Inc., Filed With SEC on December 30, 2024)
Form of Independent Contractor Agreement, dated November 19, 2024, by and between Virpax Pharmaceuticals, Inc. and Jat Consulting Corp., the personal corporation of Mr. Jatinder... (Virpax Pharmaceuticals, Inc., Filed With SEC on November 22, 2024)
Form of Independent Contractor Agreement, dated November 18, 2024, by and between Virpax Pharmaceuticals, Inc. and Chaudhry U Consulting Inc (Virpax Pharmaceuticals, Inc., Filed With SEC on November 20, 2024)
Consulting Agreement dated as of August 26, 2024 between Can B Corp. and Magna Global Ventures, LLC (Canbiola, Inc., Filed With SEC on November 19, 2024)
Consulting Agreement dated as of July 29, 2024 between Nascent Pharma, LLC and Vivid Integrated Solutions, LLC (Canbiola, Inc., Filed With SEC on November 19, 2024)
Consulting Agreement dated August 9, 2024 between Iterum Therapeutics International Limited and Dr. Michael W. Dunne (Iterum Therapeutics plc, Filed With SEC on November 14, 2024)
CFO Consulting Agreement, by and between Apimeds Pharmaceuticals US, Inc. and Mark Corrao, dated October 4, 2024 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on November 8, 2024)
Consulting Agreement by and between the Registrant and Christopher Krueger, dated April 5, 2024, as amended by Amendment No. 1 to Consulting Agreement, dated September 10, 2024 (Ventyx Biosciences, Inc., Filed With SEC on November 7, 2024)
Amendment #1, dated September 1, 2022, to the Consulting Agreement, dated October 19, 2020, between SIGA Technologies, Inc. and Tides Group, LLC (SIGA TECHNOLOGIES INC, Filed With SEC on November 7, 2024)
Consulting Agreement, dated October 19, 2020, between SIGA Technologies, Inc. and Tides Group, LLC (SIGA TECHNOLOGIES INC, Filed With SEC on November 7, 2024)
Consulting Services Agreement, dated as of September 28, 2024, by and between the Registrant and David Clark, MBChB, MRCP (Trevi Therapeutics, Inc., Filed With SEC on November 6, 2024)
Non-Healthcare Professional Consulting Agreement, effective October 1, 2024, between the Registrant and Charles. A. Reinhart, III (Pacira Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
Release and Consulting Agreement, dated as of August 30, 2024, by and between the Registrant and Joseph Bonaccorso (Verrica Pharmaceuticals Inc., Filed With SEC on November 5, 2024)
Consulting Agreement between Vireo Growth Inc. and Joshua Rosen dated October 10, 2024 (Vireo Health International, Inc., Filed With SEC on October 15, 2024)
Barbier Consulting Agreement dated September 13, 2024 (CASSAVA SCIENCES INC, Filed With SEC on September 17, 2024)
Consulting Agreement, dated August 14, 2024, between Zomedica Inc. and Peter Donato (Zomedica Pharmaceuticals Corp., Filed With SEC on August 14, 2024)
Consulting Agreement dated May 29, 2024 between Iterum Therapeutics International Limited and Dr. Sailaja Puttagunta (Iterum Therapeutics plc, Filed With SEC on August 14, 2024)
Consulting Agreement between (Charlotte's Web Holdings, Inc., Filed With SEC on August 8, 2024)
Consulting Agreement, dated as of August 2, 2024, by and between Intra-Cellular Therapies, Inc. and Lawrence J. Hineline (Intra-Cellular Therapies, Inc., Filed With SEC on August 7, 2024)
Fifth Amendment to Consulting Agreement, dated June 12, 2024, between the Registrant and Gary Pace (Pacira Pharmaceuticals, Inc., Filed With SEC on July 30, 2024)
Amendment No. 3 to Consulting Agreement, dated as of July 15, 2024, by and between Pulmatrix, Inc. and Danforth Advisors, LLC (Pulmatrix, Inc., Filed With SEC on July 19, 2024)
Consulting Agreement by and between the Company and Christopher Krueger, dated April 5, 2024 (Ventyx Biosciences, Inc., Filed With SEC on April 5, 2024)
Amendment to Consulting Agreement dated December 27, 2023 between Iterum Therapeutics International Limited and Dr. Michael Dunne (Iterum Therapeutics plc, Filed With SEC on March 28, 2024)
Consulting Services Agreement by and among the Company, iAnthus Capital Management, LLC and Robert Galvin dated October 11, 2023 (iANTHUS CAPITAL HOLDINGS, INC., Filed With SEC on March 28, 2024)
Consulting Agreement with Dr. Jay Kranzler, dated December 1, 2020 (AVENUE THERAPEUTICS, INC., Filed With SEC on March 18, 2024)
First Amendment to Consulting Agreement, by and between Registrant and Thomas Ciulla, dated as of February 17, 2024 (Clearside Biomedical, Inc., Filed With SEC on March 12, 2024)
Consulting Agreement dated December 18, 2023 by and between Eyepoint Pharmaceuticals, Inc. and John Landis, PhD (EyePoint Pharmaceuticals, Inc., Filed With SEC on March 8, 2024)
Amendment, dated January 8, 2024, to Consulting Agreements by and between Oramed Ltd. and KNRY, Ltd., entered into as of July 1, 2008, for the services of Miriam Kidron (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2024)
Amendment, dated April 27, 2023, to Consulting Agreements by and between Oramed Ltd. and KNRY, Ltd., entered into as of July 1, 2008, for the services of Miriam Kidron (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2024)
Amendment, dated January 8, 2024, to Consulting Agreement by and between Oramed Pharmaceuticals Inc. and Shnida Ltd., entered into as of November 1, 2022, for the services of... (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2024)
Amendment, dated April 27, 2023, to Consulting Agreement by and between Oramed Pharmaceuticals Inc. and Shnida Ltd., entered into as of November 1, 2022, for the services of Nadav... (ORAMED PHARMACEUTICALS INC., Filed With SEC on March 6, 2024)
Retirement and Operating Consulting Agreement and Release with Rajiv Malik, dated October 20, 2023 (Upjohn Inc, Filed With SEC on February 28, 2024)
Consulting Agreement, dated November 20, 2023, by and between the Registrant and William J. Sandborn (Ventyx Biosciences, Inc., Filed With SEC on February 27, 2024)
Consulting Agreement, dated February 20, 2024, by and between Sergio Santillana and Ikena Oncology, Inc (Ikena Oncology, Inc., Filed With SEC on February 21, 2024)
Consulting Agreement, dated January 23, 2024, by and between Stone Blossom Capital, LLC and MedMen Enterprises Inc (MedMen Enterprises, Inc., Filed With SEC on January 30, 2024)
Consulting Agreement between the Company and Michael Moses (COSMO VENTURES INC, Filed With SEC on December 14, 2023)
Consulting Agreement between RespireRx Pharmaceuticals Inc. and Ponto Ventures LLC dated December 6, 2023 (RespireRx Pharmaceuticals Inc., Filed With SEC on December 11, 2023)
Consulting Agreement, by and between Theseus Pharmaceuticals, Inc. and David Kerstein, M.D., effective as of December 7, 2023 (Theseus Pharmaceuticals, Inc., Filed With SEC on December 4, 2023)
Consulting Agreement, by and between Theseus Pharmaceuticals, Inc. and Timothy P. Clackson, Ph.D., effective as of December 7, 2023 (Theseus Pharmaceuticals, Inc., Filed With SEC on December 4, 2023)